- Home
- SRPT vs GGAL Comparison
SRPT vs GGAL Comparison
Compare SRPT & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- GGAL
- Stock Information
- Founded
- SRPT 1980
- GGAL 1905
- Country
- SRPT United States
- GGAL Argentina
- Employees
- SRPT N/A
- GGAL N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- GGAL Commercial Banks
- Sector
- SRPT Health Care
- GGAL Finance
- Exchange
- SRPT Nasdaq
- GGAL Nasdaq
- Market Cap
- SRPT 9.8B
- GGAL 9.5B
- IPO Year
- SRPT 1997
- GGAL N/A
- Fundamental
- Price
- SRPT $70.40
- GGAL $55.72
- Analyst Decision
- SRPT Buy
- GGAL Strong Buy
- Analyst Count
- SRPT 21
- GGAL 4
- Target Price
- SRPT $164.05
- GGAL $59.00
- AVG Volume (30 Days)
- SRPT 2.2M
- GGAL 948.5K
- Earning Date
- SRPT 04-30-2025
- GGAL 01-01-0001
- Dividend Yield
- SRPT N/A
- GGAL 4.20%
- EPS Growth
- SRPT N/A
- GGAL 119.80
- EPS
- SRPT 2.34
- GGAL 1.06
- Revenue
- SRPT $1,901,979,000.00
- GGAL $6,780,451,633.00
- Revenue This Year
- SRPT $67.83
- GGAL $7.05
- Revenue Next Year
- SRPT $25.66
- GGAL N/A
- P/E Ratio
- SRPT $30.71
- GGAL $7.14
- Revenue Growth
- SRPT 52.97
- GGAL N/A
- 52 Week Low
- SRPT $70.91
- GGAL $23.53
- 52 Week High
- SRPT $173.25
- GGAL $74.00
- Technical
- Relative Strength Index (RSI)
- SRPT 28.10
- GGAL 44.79
- Support Level
- SRPT $70.91
- GGAL $55.58
- Resistance Level
- SRPT $76.67
- GGAL $60.30
- Average True Range (ATR)
- SRPT 4.03
- GGAL 2.62
- MACD
- SRPT -1.50
- GGAL 0.20
- Stochastic Oscillator
- SRPT 2.28
- GGAL 37.39
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.